Francesca Sangalli

1.3k total citations
53 papers, 870 citations indexed

About

Francesca Sangalli is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Francesca Sangalli has authored 53 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 16 papers in Neurology and 14 papers in Oncology. Recurrent topics in Francesca Sangalli's work include Multiple Sclerosis Research Studies (29 papers), Polyomavirus and related diseases (12 papers) and Peripheral Neuropathies and Disorders (10 papers). Francesca Sangalli is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), Polyomavirus and related diseases (12 papers) and Peripheral Neuropathies and Disorders (10 papers). Francesca Sangalli collaborates with scholars based in Italy, France and Germany. Francesca Sangalli's co-authors include Lucia Moiola, Gıancarlo Comı, Vittorio Martinelli, Marta Radaelli, B. Colombo, Gloria Dalla Costa, Roberto Furlan, Massimo Filippi, Patricia Vrignaud and F Cohadon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Brain.

In The Last Decade

Francesca Sangalli

49 papers receiving 851 citations

Peers

Francesca Sangalli
In Hye Jeong South Korea
Kirill A. Lyapichev United States
George J. Hutton United States
Anne Cotleur United States
AeRan Joung South Korea
In Hye Jeong South Korea
Francesca Sangalli
Citations per year, relative to Francesca Sangalli Francesca Sangalli (= 1×) peers In Hye Jeong

Countries citing papers authored by Francesca Sangalli

Since Specialization
Citations

This map shows the geographic impact of Francesca Sangalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Sangalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Sangalli more than expected).

Fields of papers citing papers by Francesca Sangalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Sangalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Sangalli. The network helps show where Francesca Sangalli may publish in the future.

Co-authorship network of co-authors of Francesca Sangalli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Sangalli. A scholar is included among the top collaborators of Francesca Sangalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Sangalli. Francesca Sangalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa, Gloria Dalla, Letizia Leocani, Marco Pisa, et al.. (2024). Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres. Multiple Sclerosis Journal. 30(11-12). 1561–1565. 3 indexed citations
2.
Ferrè, Laura, Ferdinando Clarelli, Francesca Sangalli, et al.. (2022). Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients. Journal of Neurology. 269(10). 5596–5605.
3.
Montini, Federico, Vittorio Martinelli, Francesca Sangalli, et al.. (2021). Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia. Neurological Sciences. 42(10). 4373–4375. 4 indexed citations
4.
Valsasina, Paola, et al.. (2021). Dynamic Functional Connectivity in the Main Clinical Phenotypes of Multiple Sclerosis. Brain Connectivity. 11(8). 678–690. 13 indexed citations
5.
Gelibter, Stefano, Marco Pisa, Tommaso Croese, et al.. (2021). Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?. Journal of Neurology. 268(2). 717–723. 23 indexed citations
6.
Moiola, Lucia, Agostino Nozzolillo, Stefano Gelibter, et al.. (2020). Telemedicine in/outside the pandemic: A survey about satisfaction of this tool in a cohort of multiple sclerosis patients and their neurologists. Multiple Sclerosis Journal. 26. 435–435. 1 indexed citations
7.
Comı, Gıancarlo, Carlo Pozzilli, Vincenzo Brescia Morra, et al.. (2020). Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study. Neurological Sciences. 41(10). 2843–2851. 10 indexed citations
8.
Costa, Gloria Dalla, Marzia Romeo, Francesca Sangalli, et al.. (2019). Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis. Frontiers in Immunology. 10. 1922–1922. 12 indexed citations
9.
Martinelli, Vittorio, Gloria Dalla Costa, Francesca Sangalli, et al.. (2018). Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation. Multiple Sclerosis and Related Disorders. 28. 57–59. 1 indexed citations
10.
Costa, Gloria Dalla, Marta Radaelli, Simona Maida, et al.. (2017). Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice. Journal of the Neurological Sciences. 383. 166–168. 27 indexed citations
11.
Preziosa, Paolo, Francesca Sangalli, Federica Esposito, et al.. (2016). Clinical deterioration due to co-occurrence of multiple sclerosis and glioblastoma: report of two cases. Neurological Sciences. 38(2). 361–364. 8 indexed citations
12.
Radaelli, Marta, Lucia Moiola, Francesca Sangalli, et al.. (2015). Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients. Multiple Sclerosis Journal. 22(4). 511–519. 70 indexed citations
13.
Sangalli, Francesca, Lucia Moiola, Laura Ferrè, et al.. (2014). Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 3(4). 520–526. 28 indexed citations
14.
Ferrè, Laura, Lucia Moiola, Francesca Sangalli, et al.. (2014). Recurrence of disease activity after repeated Natalizumab withdrawals. Neurological Sciences. 36(3). 465–467. 10 indexed citations
15.
Radaelli, Marta, Arianna Merlini, Raffaella Greco, et al.. (2014). Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis. Current Neurology and Neuroscience Reports. 14(9). 478–478. 23 indexed citations
16.
Peruzzotti‐Jametti, Luca, Davide Strambo, Francesca Sangalli, et al.. (2012). Bilateral Intracavernous Carotid Artery Occlusion Caused by Invasive Lymphocytic Hypophysitis. Journal of Stroke and Cerebrovascular Diseases. 21(8). 918.e9–918.e11. 6 indexed citations
17.
Penfornis, Alfred, et al.. (2011). Current insulin therapy in patients with type 2 diabetes: Results of the ADHOC survey in France. Diabetes & Metabolism. 37(5). 440–445. 16 indexed citations
18.
Baldi, Isabelle, A. Grüber, Ahmadou Alioum, et al.. (2011). Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro-Oncology. 13(12). 1370–1378. 68 indexed citations
19.
Sangalli, Francesca, Lucia Moiola, Sebastiano Bucello, et al.. (2010). Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study. Neurological Sciences. 31(S3). 299–302. 45 indexed citations
20.
Sangalli, Francesca, Patricia Vrignaud, Jacques Robert, J.M. Coindre, & F Cohadon. (1989). Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats. Journal of Neuro-Oncology. 7(3). 299–304. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026